Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters.
Two cases of myoclonic encephalopathy due to bismuth salts intoxication are reported. In both, treatment with dimercaprol led to clinical recovery. This therapy was shown to enhance bismuth clearance. We also present data on the CSF metabolites dopamine, norepinephrine and serotonin of one patient.
Molina
J A
JA
Department of Neurology, Doce de Octubre, University Hospital, Madrid, Spain.
Calandre
L
L
Bermejo
F
F
D000328:Adult; D000368:Aged; D004112:Dimercaprol / Q000627:therapeutic use; D004831:Epilepsies, Myoclonic / Q000134:cerebrospinal fluid / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005707:Gallic Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid*; D009942:Organometallic Compounds / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000134:cerebrospinal fluid / Q000139:chemically induced* / Q000188:drug therapy
D018377:Neurotransmitter Agents; D009942:Organometallic Compounds; D004112:Dimercaprol; D005707:Gallic Acid; C002170:bismuth subgallate